<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0"><channel><title>Individual feed for https://stocktwits.com/sitemap/rss_feed.xml</title><link>https://stocktwits.com/sitemap/rss_feed.xml</link><description>Individual feed output.</description><lastBuildDate>Sun, 07 Sep 2025 22:37:48 GMT</lastBuildDate><generator>PyRSS2Gen-1.1.0</generator><docs>http://blogs.law.harvard.edu/tech/rss</docs><item><title>OpenAI Ventures Into Cinema With AI-Powered Animation Movie Set To Debut At Cannes: Report</title><link>https://stocktwits.com/news-articles/markets/equity/open-ai-ventures-into-cinema-with-ai-powered-animation-movie-set-to-debut-at-cannes-report/chwW1VdRdqw</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture5.png</image_url><description>The creators of "Critterz," an adventure comedy, plan to feed character sketches into OpenAI's tools, including GPT-5 and image-generating models.</description><pubDate>Mon, 08 Sep 2025 03:28:36 GMT</pubDate></item><item><title>Hesai To Raise $497M In Hong Kong After Pentagon Blacklist And US Delisting Risks</title><link>https://stocktwits.com/news-articles/markets/equity/hesai-to-raise-497-m-in-hong-kong-after-pentagon-blacklist-and-us-delisting-risks/chwW1V2Rdqv</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture6.png</image_url><description>The worldâ€™s top lidar maker reported stronger Q1 results and is pursuing a Hong Kong debut as U.S. delisting risks drive Chinese firms to seek dual li...</description><pubDate>Mon, 08 Sep 2025 03:28:33 GMT</pubDate></item><item><title>Retail Traders Flock To Summit Therapeutics After New Cancer Drug Data Shows Survival Gains</title><link>https://stocktwits.com/news-articles/markets/equity/retail-traders-flock-to-summit-therapeutics-after-new-cancer-drug-data-shows-survival-gains/chwW19jRdqH</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture9.png</image_url><description>The updated Phase III HARMONi trial showed Western patients on ivonescimab lived a median 17 months versus 14 months on chemotherapy.</description><pubDate>Mon, 08 Sep 2025 03:15:58 GMT</pubDate></item><item><title>AppLovin Retail Traders Stay Cautious After AdTech Company Makes The Cut For S&amp;P 500 Inclusion</title><link>https://stocktwits.com/news-articles/markets/equity/app-lovin-retail-traders-stay-cautious-after-s-and-p-500-inclusion/chwW176Rdqu</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture9.png</image_url><description>Shrugging off the short attacks, AppLovin reported strong second-quarter results in early August.</description><pubDate>Mon, 08 Sep 2025 03:14:01 GMT</pubDate></item><item><title>AppLovin Retail Traders Stay Cautious After AdTech Company Makes The Cut For S&amp;P 500 Inclusion</title><link>https://stocktwits.com/news-articles/markets/equity/app-lovin-retail-traders-stay-cautious-after-s-and-p-500-inclusion/chwW176Rdqu</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture8.png</image_url><description>Shrugging off the short attacks, AppLovin reported strong second-quarter results in early August.</description><pubDate>Mon, 08 Sep 2025 03:14:01 GMT</pubDate></item></channel></rss>